These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 1378879)
41. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus. van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256 [TBL] [Abstract][Full Text] [Related]
42. The human parainfluenza virus type-1 prototypic strain contains a heat-labile hemagglutinin-neuraminidase protein. Takimoto T; Portner A Virus Res; 1994 Apr; 32(1):85-92. PubMed ID: 8030367 [TBL] [Abstract][Full Text] [Related]
43. Characterization of monoclonal antibodies against four structural proteins of rinderpest virus. Sugiyama M; Minamoto N; Kinjo T; Hirayama N; Sasaki H; Yoshikawa Y; Yamanouchi K J Gen Virol; 1989 Oct; 70 ( Pt 10)():2605-13. PubMed ID: 2477496 [TBL] [Abstract][Full Text] [Related]
44. The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells. Orvell C; Kristensson K Arch Virol; 1985; 86(1-2):1-15. PubMed ID: 2994598 [TBL] [Abstract][Full Text] [Related]
45. N-glycosylation contributes to the limited cross-reactivity between hemagglutinin neuraminidase proteins of human parainfluenza virus type 4A and 4B. Komada H; Ito M; Nishio M; Kawano M; Ohta H; Tsurudome M; Kusagawa S; O'Brien M; Bando H; Ito Y Med Microbiol Immunol; 2000 Sep; 189(1):1-6. PubMed ID: 11034551 [TBL] [Abstract][Full Text] [Related]
46. Antigenic variation of envelope and internal proteins of mumps virus strains detected with monoclonal antibodies. Rydbeck R; Löve A; Orvell C; Norrby E J Gen Virol; 1986 Feb; 67 ( Pt 2)():281-7. PubMed ID: 2418151 [TBL] [Abstract][Full Text] [Related]
47. Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection. Sangster M; Smith FS; Coleclough C; Hurwitz JL Virology; 1995 Sep; 212(1):13-9. PubMed ID: 7676623 [TBL] [Abstract][Full Text] [Related]
48. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404 [TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. Randall RE; Young DF; Goswami KK; Russell WC J Gen Virol; 1987 Nov; 68 ( Pt 11)():2769-80. PubMed ID: 2445904 [TBL] [Abstract][Full Text] [Related]
50. Antigenic and functional characterization of rinderpest virus envelope proteins using monoclonal antibodies. Sugiyama M; Minamoto N; Kinjo T; Hirayama N; Asano K; Tsukiyama-Kohara K; Yoshikawa Y; Yamanouchi K J Gen Virol; 1991 Aug; 72 ( Pt 8)():1863-9. PubMed ID: 1714940 [TBL] [Abstract][Full Text] [Related]
51. Strain variation in parainfluenza virus type 4. Komada H; Orstavik I; Ito Y; Norrby E J Gen Virol; 1990 Jul; 71 ( Pt 7)():1581-3. PubMed ID: 1695674 [TBL] [Abstract][Full Text] [Related]
52. Immunological relationships between phocid and canine distemper virus studied with monoclonal antibodies. Orvell C; Blixenkrone-Möller M; Svansson V; Have P J Gen Virol; 1990 Sep; 71 ( Pt 9)():2085-92. PubMed ID: 1698923 [TBL] [Abstract][Full Text] [Related]
53. Mapping of domains on the human parainfluenza type 2 virus P and NP proteins that are involved in the interaction with the L protein. Nishio M; Tsurudome M; Ito M; Ito Y Virology; 2000 Aug; 273(2):241-7. PubMed ID: 10915594 [TBL] [Abstract][Full Text] [Related]
54. Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities. Yewdell J; Gerhard W J Immunol; 1982 Jun; 128(6):2670-5. PubMed ID: 6281335 [TBL] [Abstract][Full Text] [Related]
55. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Hu S; Wang T; Liu Y; Meng C; Wang X; Wu Y; Liu X Vet Microbiol; 2010 Jan; 140(1-2):92-7. PubMed ID: 19729254 [TBL] [Abstract][Full Text] [Related]
56. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298 [TBL] [Abstract][Full Text] [Related]
57. Effects of ectodomain sequences between HR1 and HR2 of F1 protein on the specific membrane fusion in paramyxoviruses. Ren G; Wang Z; Hu X Intervirology; 2007; 50(2):115-22. PubMed ID: 17191013 [TBL] [Abstract][Full Text] [Related]
58. Role of N-linked glycosylation of the human parainfluenza virus type 3 hemagglutinin-neuraminidase protein. Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang Z Virus Res; 2013 Jun; 174(1-2):137-47. PubMed ID: 23562646 [TBL] [Abstract][Full Text] [Related]
59. Monoclonal antibodies specific for Sendai virus. I. Production and characterization of monoclonal antibodies. Fenner M; Binz H Scand J Immunol; 1986 Sep; 24(3):335-40. PubMed ID: 2428098 [TBL] [Abstract][Full Text] [Related]
60. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]